264 related articles for article (PubMed ID: 15897481)
1. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
Lindmark S; Lönn L; Wiklund U; Tufvesson M; Olsson T; Eriksson JW
Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
[TBL] [Abstract][Full Text] [Related]
2. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women.
Faria AN; Ribeiro Filho FF; Gouveia Ferreira SR; Zanella MT
Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663
[TBL] [Abstract][Full Text] [Related]
3. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
4. [Serum adiponectin concentration in relation to body fat distribution and tissue insulin sensitivity in the glucose clamp study].
Chen L; Xiang KS; Jia WP; Lu JX; Bao YQ; Lu HJ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1456-9. PubMed ID: 16061021
[TBL] [Abstract][Full Text] [Related]
5. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
6. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
Burén J; Lindmark S; Renström F; Eriksson JW
Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
[TBL] [Abstract][Full Text] [Related]
7. Body fat distribution modulates insulin sensitivity in post-menopausal overweight and obese women: a MONET study.
Tousignant B; Faraj M; Conus F; Garrel D; Brochu M; Rabasa-Lhoret R; Coderre L
Int J Obes (Lond); 2008 Nov; 32(11):1626-32. PubMed ID: 18838980
[TBL] [Abstract][Full Text] [Related]
8. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
[TBL] [Abstract][Full Text] [Related]
9. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
[TBL] [Abstract][Full Text] [Related]
10. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement.
Munoz J; Derstine A; Gower BA
Obes Res; 2002 Jun; 10(6):424-31. PubMed ID: 12055317
[TBL] [Abstract][Full Text] [Related]
11. Abdominal adiposity and insulin resistance in obese men.
Ross R; Aru J; Freeman J; Hudson R; Janssen I
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E657-63. PubMed ID: 11832370
[TBL] [Abstract][Full Text] [Related]
12. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
13. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention.
Thamer C; Machann J; Stefan N; Haap M; Schäfer S; Brenner S; Kantartzis K; Claussen C; Schick F; Haring H; Fritsche A
Obesity (Silver Spring); 2007 Feb; 15(2):531-8. PubMed ID: 17299127
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in the first-degree relatives of persons with type 2 diabetes.
Straczkowski M; Kowalska I; Stepień A; Dzienis-Straczkowska S; Szelachowska M; Kinalska I; Krukowska A; Konicka M
Med Sci Monit; 2003 May; 9(5):CR186-90. PubMed ID: 12761455
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycaemic levels: potential impact for glucotoxicity in vivo.
Lindmark S; Burén J; Eriksson JW
Clin Endocrinol (Oxf); 2006 Sep; 65(3):301-9. PubMed ID: 16918948
[TBL] [Abstract][Full Text] [Related]
16. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
17. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity.
Gan SK; Kriketos AD; Poynten AM; Furler SM; Thompson CH; Kraegen EW; Campbell LV; Chisholm DJ
Obes Res; 2003 Nov; 11(11):1295-305. PubMed ID: 14627749
[TBL] [Abstract][Full Text] [Related]
18. Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state.
Nannipieri M; Bonotti A; Anselmino M; Cecchetti F; Madec S; Mancini E; Baldi S; Santini F; Pinchera A; Rossi M; Ferrannini E
Int J Obes (Lond); 2007 Dec; 31(12):1843-8. PubMed ID: 17607322
[TBL] [Abstract][Full Text] [Related]
19. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance of protein metabolism in type 2 diabetes.
Pereira S; Marliss EB; Morais JA; Chevalier S; Gougeon R
Diabetes; 2008 Jan; 57(1):56-63. PubMed ID: 17940118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]